Register
Journal Updates
eMediNexus Coverage from: 
Immunotherapy-related pruritus among patients with cancer is common
eMediNexus,  01 January 2019
remove_red_eye 613 Views
#Allergy and Immunology #Dermatology #Oncology

0 Read Comments                

According to a new research published online Dec. 12, 2018 in JAMA Dermatology, pruritus is a common adverse event associated with the use of immunotherapies for the treatment of cancer and can significantly compromise quality of life and overall function.
Read the full story.
Create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now